New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.

The experimental drug daraxonrasib, which doubled survival time in patients with advanced pancreatic cancer, may also prove effective for lung, colon and ovarian cancers.

The highly anticipated results of a clinical trial for the pill, daraxonrasib, have been released, giving doctors hope for treating the stubbornly lethal disease.

Eight people who had surgery for pancreatic cancer and then received a vaccine built from their own tumor DNA have now gone more than three years without any sign the disease has returned. In a cancer where most patients relapse within two years of an operation,

First-in-human pancreatic cancer trial at WVU tests an implant that delivers chemotherapy directly into tumors using low-voltage electric pulses. The WVU Cancer Institute is helping lead a global first in pancreatic cancer research with the launch of a first-in-human clinical trial testing a small implant designed to deliver chemotherapy directly into pancreatic tumors.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Adults with obesity who underwent bariatric surgery had lower risk for pancreatic cancer than those who did not ...

Surgery alone offered improved survival and a potential cure for select pancreatic cancer patients. Clear surgical margins and negative lymph node status were essential to better survival. The findings came from a registry database, not a randomized ...

A small but striking study is giving cancer researchers another reason to closely watch a new kind of treatment.An experimental personalized mRNA vaccine showed lasting results in some patients with pancreatic cancer,

The San Diego company says its blood test can detect pancreatic cancer when curative surgery may still be an option.